selected publications
- Central Nervous System Lymphoma: Approach to Diagnosis and Treatment. Cancer journal (Sudbury, Mass.). 2020 Information Resource GET IT
-
Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.
Nature.
2019
Academic Article
GET IT
Times cited: 383 -
Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma.
Blood.
2018
Academic Article
GET IT
Times cited: 179 -
Phase 1 study of pomalidomide and dexamethasone for relapsed/refractory primary CNS or vitreoretinal lymphoma.
Blood.
2018
Academic Article
GET IT
Times cited: 102 -
Pretreatment dynamic contrast-enhanced MRI biomarkers correlate with progression-free survival in primary central nervous system lymphoma.
Journal of neuro-oncology.
2018
Academic Article
GET IT
Times cited: 17 -
Treatment of Primary Central Nervous System Lymphoma: From Chemotherapy to Small Molecules.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting.
2018
Information Resource
GET IT
Times cited: 13 -
The elderly left behind-changes in survival trends of primary central nervous system lymphoma over the past 4 decades.
Neuro-oncology.
2018
Academic Article
GET IT
Times cited: 168 -
Updates on Primary Central Nervous System Lymphoma.
Current oncology reports.
2018
Information Resource
GET IT
Times cited: 35 -
Retrospective review of safety and efficacy of programmed cell death-1 inhibitors in refractory high grade gliomas.
Journal for immunotherapy of cancer.
2017
Academic Article
GET IT
Times cited: 47 -
EGFR feedback-inhibition by Ran-binding protein 6 is disrupted in cancer.
Nature communications.
2017
Academic Article
GET IT
Times cited: 20 -
Comparing sequencing assays and human-machine analyses in actionable genomics for glioblastoma.
Neurology. Genetics.
2017
Academic Article
GET IT
Times cited: 34 -
Primary CNS Lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2017
Review
GET IT
Times cited: 395 -
Ibrutinib Unmasks Critical Role of Bruton Tyrosine Kinase in Primary CNS Lymphoma.
Cancer discovery.
2017
Academic Article
GET IT
Times cited: 309 -
Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2016
Academic Article
GET IT
Times cited: 296 -
Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2016
Academic Article
GET IT
Times cited: 93 -
Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
The oncologist.
2015
Academic Article
GET IT
Times cited: 76 -
R-MPV followed by high-dose chemotherapy with TBC and autologous stem-cell transplant for newly diagnosed primary CNS lymphoma.
Blood.
2015
Academic Article
GET IT
Times cited: 265 -
Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2014
Academic Article
GET IT
Times cited: 86 -
Bevacizumab for the treatment of high-grade glioma: an update after phase III trials.
Expert opinion on biological therapy.
2014
Information Resource
GET IT
Times cited: 34 -
Retrospective analysis of the effects of steroid therapy and antidiabetic medication on survival in diabetic glioblastoma patients.
CNS oncology.
2013
Academic Article
GET IT
Times cited: 33 -
An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells.
Science (New York, N.Y.).
2013
Academic Article
GET IT
Times cited: 953 -
The PPARĪ³ agonist pioglitazone crosses the blood-brain barrier and reduces tumor growth in a human xenograft model.
Cancer chemotherapy and pharmacology.
2013
Academic Article
GET IT
Times cited: 45 - Nervous system metastases from malignant mesothelioma. Clinical oncology (Royal College of Radiologists (Great Britain)). 2012 Article GET IT
-
Bevacizumab for the treatment of high-grade glioma.
Expert opinion on biological therapy.
2012
Information Resource
GET IT
Times cited: 18 -
Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors.
Cancer discovery.
2012
Academic Article
GET IT
Times cited: 278 -
"Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.
Neuro-oncology.
2011
Academic Article
GET IT
Times cited: 307 -
The stepping test: a step back in history.
Journal of the history of the neurosciences.
2011
Academic Article
GET IT
Times cited: 13 -
Treatment of epidural spinal cord involvement from germ cell tumors with chemotherapy.
Cancer.
2010
Academic Article
GET IT
Times cited: 8 -
Inverse association of PPARĪ³ agonists use and high grade glioma development.
Journal of neuro-oncology.
2010
Academic Article
GET IT
Times cited: 21 - Corpus callosum dysgenesis limits MRI changes to one hemisphere in status epilepticus. Neurology. 2009 Article GET IT
-
Regulation of microglial phagocytosis and inflammatory gene expression by Gas6 acting on the Axl/Mer family of tyrosine kinases.
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology.
2007
Academic Article
GET IT
Times cited: 122 -
Inhibition of in vivo glioma growth and invasion by peroxisome proliferator-activated receptor gamma agonist treatment.
Molecular pharmacology.
2006
Academic Article
GET IT
Times cited: 81 -
Fibrillar beta-amyloid-stimulated intracellular signaling cascades require Vav for induction of respiratory burst and phagocytosis in monocytes and microglia.
The Journal of biological chemistry.
2006
Academic Article
GET IT
Times cited: 117 -
The nonthiazolidinedione tyrosine-based peroxisome proliferator-activated receptor gamma ligand GW7845 induces apoptosis and limits migration and invasion of rat and human glioma cells.
The Journal of pharmacology and experimental therapeutics.
2005
Academic Article
GET IT
Times cited: 24 -
Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.
The Lancet. Oncology.
2004
Information Resource
GET IT
Times cited: 385 -
Different mechanisms of secondary neuronal damage in thalamic nuclei after focal cerebral ischemia in rats.
Stroke.
2002
Academic Article
GET IT
Times cited: 98 -
Induction of apoptosis in human and rat glioma by agonists of the nuclear receptor PPARgamma.
Journal of neurochemistry.
2002
Academic Article
GET IT
Times cited: 124 -
Retinal ischemia induced by the intraluminal suture method in rats.
Neuroscience letters.
1997
Academic Article
GET IT
Times cited: 36